Management of postpartum cesarean section morbidity.
D000038:Abscess / Q000601:surgery; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002585:Cesarean Section; D002981:Clindamycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004716:Endometritis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005323:Fetal Monitoring / Q000009:adverse effects; D005839:Gentamicins / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010388:Pelvis; D010406:Penicillins / Q000627:therapeutic use; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy* / Q000209:etiology; D012306:Risk; D013530:Surgical Wound Infection / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D002981:Clindamycin; D006493:Heparin